Safety Results Pave Way to Next Stage Trials for New Drug for Common Form of Motor Neurone Disease
August 17, 2024
August 17, 2024
BIRMINGHAM, England, Aug. 17 (TNSres) -- The University of Birmingham issued the following news:
* * *
Recently published study shows acceptable safety and tolerability for the drug of interest in patients affected by Amyotrophic Lateral Sclerosis.
* * *
Researchers from the University of Birmingham and Swedish drug development company TikoMed AB have recently published peer reviewed research in PLOS ONE providing additional support that their . . .
* * *
Recently published study shows acceptable safety and tolerability for the drug of interest in patients affected by Amyotrophic Lateral Sclerosis.
* * *
Researchers from the University of Birmingham and Swedish drug development company TikoMed AB have recently published peer reviewed research in PLOS ONE providing additional support that their . . .